Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled Trial.

Autor: Perumal Kannabiran B; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Palaniappan NA; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Manoharan T; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Paramasivam PK; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Saini JK; Department of Pulmonary Oncology, National Institute for Tuberculosis and Respiratory Diseases, New Delhi, India., Ansari MS; Department of Respiratory Medicine, Bhagwan Mahavir Medical Hospital and Research Centre, Hyderabad, India., Jayabal L; District TB office, Greater Chennai Corporation, Chennai, India., Aggarwal AN; Department of Respiratory Medicine, Post Graduate Institute of Medical Research, Chandigarh, India., Garg R; Department of Respiratory Medicine, King George's Medical University, Lucknow, India., Subramanyam B; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Thakur D; Department of Respiratory Medicine, Post Graduate Institute of Medical Research, Chandigarh, India., Pantula S; Department of Respiratory Medicine, Bhagwan Mahavir Medical Hospital and Research Centre, Hyderabad, India., P M R; Department of Respiratory Medicine, Government Thiruvotteeswarar Hospital of Thoracic Medicine, Chennai, India., Gs V; Department of Respiratory Medicine, Institute of Thoracic Medicine, Chennai, India., Natarajan S; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Ammayappan RK; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Manpreet B; Department of Pulmonary Oncology, National Institute for Tuberculosis and Respiratory Diseases, New Delhi, India., Ganesan M; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Angamuthu D; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Chinnaiyan P; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Singh M; Division of Communicable Diseases, Indian Council of Medical Research, New Delhi, India., Chandrasekaran P; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Swaminathan S; Former Chief Scientist, World Health Organisation, Geneva, Switzerland.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 02; Vol. 11 (3), pp. ofae034. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).